Full-text, online textbook discussing various pharmaceutical, neutraceutical, and lifestyle interventions for enhancing life by facilitating our efforts to reach our fullest potential. ·
http://www.hedweb.com/hedethic/tabconhi.htm
Full-text, online textbook discussing various pharmaceutical, neutraceutical, and lifestyle interventions for enhancing life by facilitating our efforts to reach our fullest potential. ·
http://www.hedweb.com/hedethic/tabconhi.htm
Even the lowest dose of modafinil, an ampakine, improved the wakefulness and cognitive performance of sleep-deprived people; they work in part by boosting glutamate, a key neurotransmitter that facilitates learning & learn and encodes memory. ·
http://nootropics.com/ampakines/smarts.html
Even the lowest dose of modafinil, an ampakine, improved the wakefulness and cognitive performance of sleep-deprived people; they work in part by boosting glutamate, a key neurotransmitter that facilitates learning & learn and encodes memory. ·
http://nootropics.com/ampakines/smarts.html
Thanks to AIDS activists it has been legal for several years in the United States to order, for personal use, a 3 month supply of non-Schedule I or II drugs, from overseas. We view International Antiaging Systems (IAS) as a reliable source. We've shared b ·
http://www.smart-publications.com/articles/overseas.php
Thanks to AIDS activists it has been legal for several years in the United States to order, for personal use, a 3 month supply of non-Schedule I or II drugs, from overseas. We view International Antiaging Systems (IAS) as a reliable source. We've shared b ·
http://www.smart-publications.com/articles/overseas.php
Surgery does not deal with the basic molecular foundation of disease. It is a mechanical approach to a biologic problem. For those of us who are considered experts in the areas of coronary disease, what an embarrassment to admit that coronary artery disea ·
http://www.heartattackproof.com/address01.htm
Surgery does not deal with the basic molecular foundation of disease. It is a mechanical approach to a biologic problem. For those of us who are considered experts in the areas of coronary disease, what an embarrassment to admit that coronary artery disea ·
http://www.heartattackproof.com/address01.htm
The morbidity, mortality, expense and transient benefits of a high technology approach toward the coronary disease epidemic, has failed. It is time to realize that the answer to a faulty lifestyle epidemic is not drugs and technology – it is lifestyle. ·
http://www.vegsource.com/articles2/esselstyn_collapse.htm
The morbidity, mortality, expense and transient benefits of a high technology approach toward the coronary disease epidemic, has failed. It is time to realize that the answer to a faulty lifestyle epidemic is not drugs and technology – it is lifestyle. ·
http://www.vegsource.com/articles2/esselstyn_collapse.htm
Modern cardiology has given up on curing heart disease. Its aggressive interventions-- coronary artery bypass graft, atherectomy, angioplasty, and stenting--do not reduce the frequency of new heart attacks or prolong survival except in small subsets of pa ·
http://www.heartattackproof.com/reversal01.htm
Modern cardiology has given up on curing heart disease. Its aggressive interventions-- coronary artery bypass graft, atherectomy, angioplasty, and stenting--do not reduce the frequency of new heart attacks or prolong survival except in small subsets of pa ·
http://www.heartattackproof.com/reversal01.htm
An unreasonable gap exists between medical enthusiasm devoted to acute interventions and meager efforts devoted to secondary prevention. Rene C. Favaloro, MD, Pioneer of Coronary Artery Bypass Graft Surgery ·
http://www.heartattackproof.com/morethan01_intro.htm
An unreasonable gap exists between medical enthusiasm devoted to acute interventions and meager efforts devoted to secondary prevention. Rene C. Favaloro, MD, Pioneer of Coronary Artery Bypass Graft Surgery ·
http://www.heartattackproof.com/morethan01_intro.htm
Our patient exemplified the challenges involved in a CTO, which included the length of the lesion, the lack of a proximal nipple, the presence of a side branch at the occlusion point, poor visualization of the distal vessel despite contralateral injection ·
http://www.cardiacinterventionstoday.com/PDFarticles/0307/CIT0307_01.php
Our patient exemplified the challenges involved in a CTO, which included the length of the lesion, the lack of a proximal nipple, the presence of a side branch at the occlusion point, poor visualization of the distal vessel despite contralateral injection ·
http://www.cardiacinterventionstoday.com/PDFarticles/0307/CIT0307_01.php